Center Variation in Chest Tube Duration and Length of Stay After Congenital Heart Surgery.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
07 2020
Historique:
received: 08 07 2019
revised: 18 09 2019
accepted: 23 09 2019
pubmed: 25 11 2019
medline: 29 8 2020
entrez: 25 11 2019
Statut: ppublish

Résumé

Nearly every child undergoing congenital heart surgery has chest tubes placed intraoperatively. Center variation in removal practices and impact on outcomes has not been well described. This study evaluated variation in chest tube management practices and outcomes across centers. The study included patients undergoing any of 10 benchmark operations from June 2017 to May 2018 at participating Pediatric Acute Care Cardiology Collaborative (PAC The cohort included 1029 patients (N = 9 centers). Median chest tube duration varied significantly across centers for 9 of 10 benchmark operations (all P ≤ .03), with a "model" center noted to have the shortest duration for 9 of 10 operations (range, 27.9% to 87.4% shorter duration vs other centers across operations). This effect persisted in multivariable analysis (P < .0001). The model center had higher volumes of chest tube output before removal (median, 8.5 mL/kg/24 h [model] vs 2.2 mL/kg/24 h [other centers]; P < .001], but it did not have higher rates of chest tube reinsertion (model center 1.3% vs 2.1%; P = .59) or readmission for pleural effusion (model center 4.4% vs 3.0%; P = .31), and had the shortest length of stay for 7 of 10 operations. This study suggests significant center variation in chest tube removal practices and associated outcomes after congenital heart surgery. Best practices used at the model center have informed the design of an ongoing collaborative learning project aimed at reducing chest tube duration and length of stay.

Sections du résumé

BACKGROUND
Nearly every child undergoing congenital heart surgery has chest tubes placed intraoperatively. Center variation in removal practices and impact on outcomes has not been well described. This study evaluated variation in chest tube management practices and outcomes across centers.
METHODS
The study included patients undergoing any of 10 benchmark operations from June 2017 to May 2018 at participating Pediatric Acute Care Cardiology Collaborative (PAC
RESULTS
The cohort included 1029 patients (N = 9 centers). Median chest tube duration varied significantly across centers for 9 of 10 benchmark operations (all P ≤ .03), with a "model" center noted to have the shortest duration for 9 of 10 operations (range, 27.9% to 87.4% shorter duration vs other centers across operations). This effect persisted in multivariable analysis (P < .0001). The model center had higher volumes of chest tube output before removal (median, 8.5 mL/kg/24 h [model] vs 2.2 mL/kg/24 h [other centers]; P < .001], but it did not have higher rates of chest tube reinsertion (model center 1.3% vs 2.1%; P = .59) or readmission for pleural effusion (model center 4.4% vs 3.0%; P = .31), and had the shortest length of stay for 7 of 10 operations.
CONCLUSIONS
This study suggests significant center variation in chest tube removal practices and associated outcomes after congenital heart surgery. Best practices used at the model center have informed the design of an ongoing collaborative learning project aimed at reducing chest tube duration and length of stay.

Identifiants

pubmed: 31760054
pii: S0003-4975(19)31710-2
doi: 10.1016/j.athoracsur.2019.09.078
pmc: PMC7959331
mid: NIHMS1675226
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-227

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR002240
Pays : United States

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Références

J Thorac Cardiovasc Surg. 2010 May;139(5):1205-10
pubmed: 20167337
Cardiol Young. 2007 Sep;17 Suppl 2:75-86
pubmed: 18039401
Ann Surg. 2008 Sep;248(3):402-10
pubmed: 18791360
Ann Thorac Surg. 2011 Dec;92(6):2184-91; discussion 2191-2
pubmed: 22115229
J Thorac Cardiovasc Surg. 2012 Oct;144(4):915-21
pubmed: 22698562
World J Pediatr Congenit Heart Surg. 2012 Jan 1;3(1):32-47
pubmed: 23804682
Pediatrics. 2012 Feb;129(2):e385-91
pubmed: 22271697
J Am Coll Cardiol. 2012 Sep 11;60(11):1018-25
pubmed: 22818071
Cardiol Young. 2015 Jun;25(5):951-7
pubmed: 25167212
Ann Thorac Surg. 2012 Aug;94(2):564-71; discussion 571-2
pubmed: 22704799
Cardiol Young. 2018 Aug;28(8):1019-1023
pubmed: 29952278
Aust Crit Care. 2001 Nov;14(4):156-60
pubmed: 11806513
World J Pediatr Congenit Heart Surg. 2010 Apr;1(1):8-14
pubmed: 22368780
Cardiol Young. 2019 Feb;29(2):111-118
pubmed: 30567622
Pediatr Crit Care Med. 2017 Jun;18(6):550-560
pubmed: 28437365
Congenit Heart Dis. 2009 Sep-Oct;4(5):318-28
pubmed: 19740186
Cardiol Young. 2018 Dec;28(12):1471-1474
pubmed: 30198449
J Thorac Cardiovasc Surg. 2016 Mar;151(3):669-675.e1
pubmed: 26519244
Pediatr Crit Care Med. 2016 Oct;17(10):939-947
pubmed: 27513600

Auteurs

Katherine E Bates (KE)

Congenital Heart Center, C.S. Mott Children's Hospital, Ann Arbor, Michigan; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan. Electronic address: kebates@med.umich.edu.

Nicolas L Madsen (NL)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.

Lara Khadr (L)

Congenital Heart Center, C.S. Mott Children's Hospital, Ann Arbor, Michigan; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.

Zhiqian Gao (Z)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.

Kari Crawford (K)

Pediatric Heart Surgery and Cardiology, Levine Children's Hospital, Charlotte, North Carolina.

Michael Gaies (M)

Congenital Heart Center, C.S. Mott Children's Hospital, Ann Arbor, Michigan; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.

Margaret Graupe (M)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.

Samuel P Hanke (SP)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, Ohio.

Anthony M Hlavacek (AM)

Children's Heart Center, Medical University of South Carolina Children's Health, Charleston, South Carolina.

Evonne Morell (E)

Heart Institute, University of Pittsburgh Medical Center Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania; Department of Pediatrics, University of Pittsburgh, Pittsburgh, Pennsylvania.

Sara K Pasquali (SK)

Congenital Heart Center, C.S. Mott Children's Hospital, Ann Arbor, Michigan; Department of Pediatrics, University of Michigan Medical School, Ann Arbor, Michigan.

Jennifer L Russell (JL)

Labatt Family Heart Centre, The Hospital for Sick Children, Toronto, Ontario, Canada.

Susan K Schachtner (SK)

Cardiac Center, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pediatrics Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ronn E Tanel (RE)

Pediatric Heart Center, UCSF Benioff Children's Hospital, San Francisco, California; Department of Pediatrics, UCSF School of Medicine, San Francisco, California.

Adam L Ware (AL)

The Heart Center, Primary Children's Hospital, Salt Lake City, Utah.

Alaina K Kipps (AK)

Betty Irene Moore Children's Heart Center, Lucile Packard Childrens Hospital at Stanford, Palo Alto, California; Department of Pediatrics, Stanford School of Medicine, Palo Alto, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH